搜尋結果
Regeneron misses profit estimates on weaker Eylea and Dupixent sales
Reuters· 10 分鐘前U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for first-quarter profit on Thursday due to softer ...
Novo Boosts Outlook as More Patients Start on Wegovy for Obesity
Bloomberg· 5 小時前Have a confidential tip for our reporters? Novo Nordisk A/S is shipping more introductory doses ...
Novo Nordisk raises outlook fuelled by obesity drug demand
Reuters· 4 小時前, opens new tab raised its 2024 outlook on Thursday and delivered better-than-expected ...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 19 分鐘前Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the ...
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 6 小時前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
Amgen investors await weight-loss drug data
Reuters· 24 小時前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...